Authors:
Khan, OA
Zvartau-Hind, M
Caon, C
Din, MU
Cochran, M
Lisak, D
Tselis, AC
Kamholz, JA
Garbern, JY
Lisak, RP
Citation: Oa. Khan et al., Effect of monthly intravenous cyclophosphamide in rapidly deteriorating multiple sclerosis patients resistant to conventional therapy, MULT SCLER, 7(3), 2001, pp. 185-188
Authors:
Khan, OA
Tselis, AC
Kamholz, JA
Garbern, JY
Lewis, RA
Lisak, RP
Citation: Oa. Khan et al., A prospective, open-label treatment trial to compare the effect of IFN beta-1a (Avonex), IFN beta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis, EUR J NEUR, 8(2), 2001, pp. 141-148
Authors:
Balabanov, R
Lisak, D
Beaumont, T
Lisak, RP
Dore-Duffy, P
Citation: R. Balabanov et al., Expression of urokinase plasminogen activator receptor on monocytes from patients with relapsing-remitting multiple sclerosis: Effect of glatiramer acetate (Copolymer 1), CL DIAG LAB, 8(6), 2001, pp. 1196-1203
Authors:
Skundric, DS
Lisak, RP
Rouhi, M
Kieseier, BC
Jung, S
Hartung, HP
Citation: Ds. Skundric et al., Schwann cell-specific regulation of IL-1 and IL-1Ra during EAN: possible relevance for immune regulation at paranodal regions, J NEUROIMM, 116(1), 2001, pp. 74-82
Authors:
Johnson, KP
Brooks, BR
Ford, CC
Goodman, A
Guarnaccia, J
Lisak, RP
Myers, LW
Panitch, HS
Pruitt, A
Rose, JW
Kachuck, N
Wolinsky, JS
Citation: Kp. Johnson et al., Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years, MULT SCLER, 6(4), 2000, pp. 255-266
Citation: Rp. Lisak, Type I interferons and chronic inflammatory demyelinating polyneuropathy: Treatment or cause?, MUSCLE NERV, 23(3), 2000, pp. 307-309
Authors:
Goldberg, SH
Albright, AV
Lisak, RP
Gonzalez-Scarano, F
Citation: Sh. Goldberg et al., Polymerase chain reaction analysis of human herpesvirus-6 sequences in thesera and cerebrospinal fluid of patients with multiple sclerosis, J NEUROVIRO, 5(2), 1999, pp. 134-139
Authors:
Ford, CC
Brooks, BR
Johnson, KP
Lisak, RP
Myers, LW
Panitch, HS
Rose, JW
Schiffer, RB
Vollmer, T
Weiner, LP
Wolinsky, JS
Citation: Cc. Ford et al., Sustained efficacy of glatiramer acetate for injection in a 5+ year trial of relapsing remitting MS, MULT SCLER, 4(6), 1998, pp. 521-521
Authors:
Lisak, RP
Bealmear, B
Benjamins, J
Skoff, A
Citation: Rp. Lisak et al., Inflammatory cytokines inhibit upregulation of glycolipid expression by Schwann cells in vitro, NEUROLOGY, 51(6), 1998, pp. 1661-1665